{"id":362472,"date":"2010-02-25T12:13:42","date_gmt":"2010-02-25T17:13:42","guid":{"rendered":"http:\/\/blogs.wsj.com\/health\/2010\/02\/25\/studies-keeping-coming-on-roches-avastin-latest-is-positive\/"},"modified":"2010-02-25T12:13:42","modified_gmt":"2010-02-25T17:13:42","slug":"studies-keeping-coming-on-roche%e2%80%99s-avastin-latest-is-positive","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/362472","title":{"rendered":"Studies Keeping Coming on Roche\u2019s Avastin; Latest Is Positive"},"content":{"rendered":"

\"avastin\"We recounted earlier this week that Roche’s cancer drug Avastin had missed achieving<\/a> its main target in a stomach-cancer study. Today the news is flipped as a new study reported Avastin showed positive results in the treatment of advanced ovarian cancer.<\/p>\n

The latest showed that women who continued using Avastin alone after receiving Avastin in combination with chemotherapy lived longer without the disease worsening, compared with those who received chemotherapy alone. The 1,873 women in the study had already undergone surgery to remove as much of their tumors as possible. Here’s the Roche announcement<\/a>. <\/p>\n

A Sanford C. Bernstein analyst told Dow Jones Newswires<\/a> that “2010 is going to see a slew more Avastin data,” including two continuing studies that test Avastin in prostate cancer and in early-stage colorectal cancer. Avastin is already approved to treat advanced colorectal, breast, lung and kidney cancer.<\/p>\n

Avastin’s sales totaled $5.75 billion last year and the drug could eventually reach peak sales of more than $8 billion if it also is approved for treating other cancers, according to DJ Newswires.<\/p>\n

Photo: Bloomberg News<\/em><\/p>\n

<\/img><\/a>
\n<\/img><\/a><\/p>\n

\n<\/img><\/a> <\/img><\/a> <\/img><\/a> <\/img><\/a> <\/img><\/a>\n<\/div>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

We recounted earlier this week that Roche’s cancer drug Avastin had missed achieving its main target in a stomach-cancer study. Today the news is flipped as a new study reported Avastin showed positive results in the treatment of advanced ovarian cancer. The latest showed that women who continued using Avastin alone after receiving Avastin in […]<\/p>\n","protected":false},"author":792,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-362472","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/362472","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/792"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=362472"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/362472\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=362472"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=362472"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=362472"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}